Showing 1–14 of 14 results
-
Correspondence |
-
Correspondence |
-
Correspondence |
-
Correspondence |
-
-
-
-
-
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit – multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group
- Y Perel
- , A Auvrignon
- , T Leblanc
- , G Michel
- , Y Reguerre
- , J-P Vannier
- , J-H Dalle
- , V Gandemer
- , C Schmitt
- , F Méchinaud
- , O Lejars
- , C Piguet
- , G Couillaud
- , B Pautard
- , J Landman-Parker
- , I Thuret
- , N Aladjidi
- , A Baruchel
- & G Leverger
Leukemia 19 , 2082–2089 -
| Open
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)
- J Donadieu
- , M-F Auclerc
- , A Baruchel
- , Y Perel
- , P Bordigoni
- , J Landman-Parker
- , T Leblanc
- , G Cornu
- , D Sommelet
- , G Leverger
- , G Schaison
- & C Hill
British Journal of Cancer 83 , 1617–1622 -
-
Research |
-
Research |
-
Research |
